Financials SI-BONE, Inc.

Equities

SIBN

US8257041090

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
14.03 USD -0.14% Intraday chart for SI-BONE, Inc. -7.15% -33.16%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 537.6 967.6 743.8 469.2 850.1 578.1 - -
Enterprise Value (EV) 1 485.1 810.6 631.8 407 720.2 480.7 491.1 486.9
P/E ratio -13.9 x -19.9 x -13 x -7.6 x -18.6 x -14.7 x -17.8 x -28.3 x
Yield - - - - - - - -
Capitalization / Revenue 7.99 x 13.2 x 8.25 x 4.41 x 6.12 x 3.5 x 2.97 x 2.55 x
EV / Revenue 7.21 x 11 x 7.01 x 3.83 x 5.19 x 2.91 x 2.52 x 2.15 x
EV / EBITDA -13.8 x -21.7 x -12.7 x -7.04 x -41.6 x -49.5 x -150 x 54.8 x
EV / FCF -14,236,252 x - - -7,955,735 x - - - -
FCF Yield -0% - - -0% - - - -
Price to Book 8.59 x 5.75 x 5.57 x 4.81 x 4.76 x 3.64 x 3.74 x 3.55 x
Nbr of stocks (in thousands) 25,005 32,361 33,490 34,496 40,501 41,205 - -
Reference price 2 21.50 29.90 22.21 13.60 20.99 14.03 14.03 14.03
Announcement Date 3/9/20 3/8/21 2/28/22 2/27/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 67.3 73.39 90.15 106.4 138.9 165.2 194.5 226.8
EBITDA 1 -35.23 -37.44 -49.58 -57.8 -17.3 -9.704 -3.263 8.89
EBIT 1 -36 -38.57 -51.67 -61.26 -46.93 -41.97 -35.15 -27.07
Operating Margin -53.5% -52.55% -57.31% -57.57% -33.79% -25.4% -18.07% -11.94%
Earnings before Tax (EBT) 1 - -43.7 -56.57 -61.26 -43.34 -40.31 -32.9 -21.28
Net income 1 -38.4 -43.7 -56.57 -61.26 -43.34 -39.49 -33.13 -21.28
Net margin -57.06% -59.54% -62.75% -57.57% -31.2% -23.9% -17.03% -9.39%
EPS 2 -1.550 -1.500 -1.710 -1.790 -1.130 -0.9538 -0.7862 -0.4960
Free Cash Flow -34.07 - - -51.16 - - - -
FCF margin -50.63% - - -48.08% - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/9/20 3/8/21 2/28/22 2/27/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 25.23 22.44 25.58 26.43 31.95 32.71 33.3 34.01 38.86 37.87 39.11 40.6 47.57 45.26 46.89
EBITDA 1 -13.28 -16.16 -17.09 -12.62 -10.29 -3.939 -10.73 -3.85 -4.811 -4.017 -4.151 -2.24 0.645 -3.116 -2.634
EBIT 1 -13.93 -16.87 -17.88 -13.57 -11.29 -11.29 -11.96 -11.17 -12.51 -12.04 -11.86 -10.11 -7.915 -10.51 -10.39
Operating Margin -55.21% -75.17% -69.89% -51.32% -35.35% -34.53% -35.92% -32.84% -32.18% -31.8% -30.33% -24.91% -16.64% -23.22% -22.15%
Earnings before Tax (EBT) 1 -14.48 -17.41 -18.51 -14.16 -11.18 -11.12 -11.21 -10.02 -10.98 -10.9 -11.72 -9.742 -7.564 -10.46 -9.477
Net income 1 -14.48 -17.41 -18.51 -14.16 -11.18 -11.12 -11.21 -10.02 -10.98 -10.9 -11.33 -9.6 -7.387 -9.64 -9.608
Net margin -57.38% -77.59% -72.36% -53.56% -34.97% -34.01% -33.65% -29.46% -28.26% -28.8% -28.98% -23.65% -15.53% -21.3% -20.49%
EPS 2 -0.4300 -0.5200 -0.5400 -0.4100 -0.3200 -0.3200 -0.3000 -0.2500 -0.2700 -0.2700 -0.2750 -0.2288 -0.1788 -0.2367 -0.2260
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/28/22 5/9/22 8/8/22 11/7/22 2/27/23 5/1/23 8/7/23 11/6/23 2/26/24 5/6/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 52.6 157 112 62.1 130 97.4 87 91.2
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -34.1 - - -51.2 - - - -
ROE (net income / shareholders' equity) -50.1% -37.6% -37.3% -52.6% -32.4% -22.9% -20.7% -14.9%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 2.500 5.200 3.990 2.830 4.410 3.850 3.750 3.950
Cash Flow per Share 2 -1.280 -1.060 -1.190 -1.220 -0.4900 -0.4600 0.0100 -
Capex 2.45 2.56 6.39 9.51 - - - -
Capex / Sales 3.63% 3.49% 7.09% 8.93% - - - -
Announcement Date 3/9/20 3/8/21 2/28/22 2/27/23 2/26/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.03 USD
Average target price
25.56 USD
Spread / Average Target
+82.15%
Consensus
  1. Stock Market
  2. Equities
  3. SIBN Stock
  4. Financials SI-BONE, Inc.